Targeted molecular therapies represent a groundbreaking approach in cancer treatment, focusing on the specific genetic mutations and protein interactions that drive tumor growth.By leveraging molecular glues—small molecules that facilitate interactions between proteins—researchers aim to disrupt the biological processes that contribute to cancer.